Luis Contreras
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Evaluation of remission in ulcerative colitis: Relationship between clinical, endoscopic, and histological markers as predictors of relapse.
Journal: Gastroenterologia y hepatologia
Published: December 18, 2024
Stricturing Crohn's disease and intestinal endometriosis: An unusual coexistence.
Journal: Revista de gastroenterologia de Mexico (English)
Published: June 14, 2024
Mesalamine induced hepatotoxicity. Is mesalamine safe?
Journal: Revista espanola de enfermedades digestivas
Published: January 11, 2024
Effectiveness of infliximab in common variable immunodeficiency associated with enteropathy.
Journal: Revista espanola de enfermedades digestivas
Published: November 06, 2023
Herpetic Esophagitis and Eosinophilic Esophagitis: A Potential Association.
Journal: The American journal of case reports
Published: September 27, 2021
Anal neoplasia and perianal Crohn's disease: myth or reality?
Journal: Revista espanola de enfermedades digestivas
Published: September 24, 2021
Infectious proctitis and perianal disease: a gaze beyond inflammatory bowel disease
Journal: Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia
Published: April 22, 2021
Leflunomide as a cause of collagenous colitis: an entity to consider.
Journal: Revista espanola de enfermedades digestivas
Published: April 19, 2021
Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse.
Journal: Ecancermedicalscience
Published: February 13, 2019
l-NIL prevents the ischemia and reperfusion injury involving TLR-4, GST, clusterin, and NFAT-5 in mice.
Journal: American journal of physiology. Renal physiology
Published: December 06, 2018
Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species.
Journal: Oncotarget
Published: January 18, 2016
Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis.
Journal: Stem cell research & therapy
Published: April 20, 2015
Last Updated: 09/26/2026